Loss of GCNT2/I-branched glycans enhances melanoma growth and survival
Aberrant glycosylation patterns on cancer cells promote several pro-tumorigenic functions, including enhancing tumor cell proliferation. Here the authors provide data that show melanoma cells downregulate GCNT2 with consequent loss of I-branched glycans; this leads to the formation of extended i-lin...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de097a28a8eb4a7595203ca85b7c7bc9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:de097a28a8eb4a7595203ca85b7c7bc9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:de097a28a8eb4a7595203ca85b7c7bc92021-12-02T15:33:45ZLoss of GCNT2/I-branched glycans enhances melanoma growth and survival10.1038/s41467-018-05795-02041-1723https://doaj.org/article/de097a28a8eb4a7595203ca85b7c7bc92018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05795-0https://doaj.org/toc/2041-1723Aberrant glycosylation patterns on cancer cells promote several pro-tumorigenic functions, including enhancing tumor cell proliferation. Here the authors provide data that show melanoma cells downregulate GCNT2 with consequent loss of I-branched glycans; this leads to the formation of extended i-linear glycans and enhances melanoma growth via increases, in part, by IGF-1- and extracellular matrix-induced signaling.Jenna Geddes SweeneyJennifer LiangAristotelis AntonopoulosNicholas GiovannoneShuli KangTony S. MondalaSteven R. HeadSandra L. KingYoshihiko TaniDanielle BrackettAnne DellGeorge F. MurphyStuart M. HaslamHans R. WidlundCharles J. DimitroffNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-18 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Jenna Geddes Sweeney Jennifer Liang Aristotelis Antonopoulos Nicholas Giovannone Shuli Kang Tony S. Mondala Steven R. Head Sandra L. King Yoshihiko Tani Danielle Brackett Anne Dell George F. Murphy Stuart M. Haslam Hans R. Widlund Charles J. Dimitroff Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
description |
Aberrant glycosylation patterns on cancer cells promote several pro-tumorigenic functions, including enhancing tumor cell proliferation. Here the authors provide data that show melanoma cells downregulate GCNT2 with consequent loss of I-branched glycans; this leads to the formation of extended i-linear glycans and enhances melanoma growth via increases, in part, by IGF-1- and extracellular matrix-induced signaling. |
format |
article |
author |
Jenna Geddes Sweeney Jennifer Liang Aristotelis Antonopoulos Nicholas Giovannone Shuli Kang Tony S. Mondala Steven R. Head Sandra L. King Yoshihiko Tani Danielle Brackett Anne Dell George F. Murphy Stuart M. Haslam Hans R. Widlund Charles J. Dimitroff |
author_facet |
Jenna Geddes Sweeney Jennifer Liang Aristotelis Antonopoulos Nicholas Giovannone Shuli Kang Tony S. Mondala Steven R. Head Sandra L. King Yoshihiko Tani Danielle Brackett Anne Dell George F. Murphy Stuart M. Haslam Hans R. Widlund Charles J. Dimitroff |
author_sort |
Jenna Geddes Sweeney |
title |
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
title_short |
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
title_full |
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
title_fullStr |
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
title_full_unstemmed |
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
title_sort |
loss of gcnt2/i-branched glycans enhances melanoma growth and survival |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/de097a28a8eb4a7595203ca85b7c7bc9 |
work_keys_str_mv |
AT jennageddessweeney lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT jenniferliang lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT aristotelisantonopoulos lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT nicholasgiovannone lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT shulikang lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT tonysmondala lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT stevenrhead lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT sandralking lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT yoshihikotani lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT daniellebrackett lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT annedell lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT georgefmurphy lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT stuartmhaslam lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT hansrwidlund lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival AT charlesjdimitroff lossofgcnt2ibranchedglycansenhancesmelanomagrowthandsurvival |
_version_ |
1718387055032008704 |